BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 14730966)

  • 1. Crystal structure of a human VH: requirements for maintaining a monomeric fragment.
    Dottorini T; Vaughan CK; Walsh MA; LoSurdo P; Sollazzo M
    Biochemistry; 2004 Jan; 43(3):622-8. PubMed ID: 14730966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of a non-camelized human M12-V(H) domain at 1.5A resolution.
    Gaur RK
    J Struct Biol; 2005 Oct; 152(1):84-9. PubMed ID: 16183303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA binding by the VH domain of anti-Z-DNA antibody and its modulation by association of the VL domain.
    Chen Y; Stollar BD
    J Immunol; 1999 Apr; 162(8):4663-70. PubMed ID: 10202006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Domain swapping of a llama VHH domain builds a crystal-wide beta-sheet structure.
    Spinelli S; Desmyter A; Frenken L; Verrips T; Tegoni M; Cambillau C
    FEBS Lett; 2004 Apr; 564(1-2):35-40. PubMed ID: 15094039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rearrangement of the former VL interface in the solution structure of a camelised, single antibody VH domain.
    Riechmann L
    J Mol Biol; 1996 Jun; 259(5):957-69. PubMed ID: 8683598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lateral recognition of a dye hapten by a llama VHH domain.
    Spinelli S; Tegoni M; Frenken L; van Vliet C; Cambillau C
    J Mol Biol; 2001 Aug; 311(1):123-9. PubMed ID: 11469862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the hepatitis C virus NS3 protease activity by Fv fragment of antibody 8D4.
    Kasai N; Tsumoto K; Niwa S; Misawa S; Ueno T; Hayashi H; Kumagai I
    Biochem Biophys Res Commun; 2001 Feb; 281(2):416-24. PubMed ID: 11181064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystallization of single-chain Fv proteins.
    Essig NZ; Wood JF; Howard AJ; Raag R; Whitlow M
    J Mol Biol; 1993 Dec; 234(3):897-901. PubMed ID: 8254684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of a shark single-domain antibody V region in complex with lysozyme.
    Stanfield RL; Dooley H; Flajnik MF; Wilson IA
    Science; 2004 Sep; 305(5691):1770-3. PubMed ID: 15319492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of a polymeric immunoglobulin binding fragment of the human polymeric immunoglobulin receptor.
    Hamburger AE; West AP; Bjorkman PJ
    Structure; 2004 Nov; 12(11):1925-35. PubMed ID: 15530357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solution structure and backbone dynamics of an antigen-free heavy chain variable domain (VHH) from Llama.
    Renisio JG; Pérez J; Czisch M; Guenneugues M; Bornet O; Frenken L; Cambillau C; Darbon H
    Proteins; 2002 Jun; 47(4):546-55. PubMed ID: 12001233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of an Fab fragment in complex with a meningococcal serosubtype antigen and a protein G domain.
    Derrick JP; Maiden MC; Feavers IM
    J Mol Biol; 1999 Oct; 293(1):81-91. PubMed ID: 10512717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody domain exchange is an immunological solution to carbohydrate cluster recognition.
    Calarese DA; Scanlan CN; Zwick MB; Deechongkit S; Mimura Y; Kunert R; Zhu P; Wormald MR; Stanfield RL; Roux KH; Kelly JW; Rudd PM; Dwek RA; Katinger H; Burton DR; Wilson IA
    Science; 2003 Jun; 300(5628):2065-71. PubMed ID: 12829775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformations of the third hypervariable region in the VH domain of immunoglobulins.
    Morea V; Tramontano A; Rustici M; Chothia C; Lesk AM
    J Mol Biol; 1998 Jan; 275(2):269-94. PubMed ID: 9466909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutual stabilization of VL and VH in single-chain antibody fragments, investigated with mutants engineered for stability.
    Wörn A; Plückthun A
    Biochemistry; 1998 Sep; 37(38):13120-7. PubMed ID: 9748318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Display of somatostatin-related peptides in the complementarity determining regions of an antibody light chain.
    Simon PJ; Brogle KC; Wang B; Kyle DJ; Soltis DA
    Arch Biochem Biophys; 2005 Aug; 440(2):148-57. PubMed ID: 16051181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A structure-based database of antibody variable domain diversity.
    Bond CJ; Wiesmann C; Marsters JC; Sidhu SS
    J Mol Biol; 2005 May; 348(3):699-709. PubMed ID: 15826665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing the dimer to monomer transition of an antibody single-chain Fv fragment.
    Arndt KM; Müller KM; Plückthun A
    Biochemistry; 1998 Sep; 37(37):12918-26. PubMed ID: 9737871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phage-displayed antibody libraries of synthetic heavy chain complementarity determining regions.
    Sidhu SS; Li B; Chen Y; Fellouse FA; Eigenbrot C; Fuh G
    J Mol Biol; 2004 Apr; 338(2):299-310. PubMed ID: 15066433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.
    Giles I; Lambrianides N; Latchman D; Chen P; Chukwuocha R; Isenberg D; Rahman A
    Arthritis Res Ther; 2005; 7(1):R47-56. PubMed ID: 15642142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.